OrthoPediatrics Corp. filed a Form 8-K with the SEC on October 27, 2026, disclosing under Regulation FD that its executive officers plan to use an investor presentation in upcoming meetings with investors and analysts.

Key Highlights

  • Filing date: October 27, 2026, reported as the date of earliest event.
  • Regulation FD disclosure: Executive officers of OrthoPediatrics Corp. intend to present materials filed as Exhibit 99.1 to representatives of investors and analysts.
  • Exhibit: Exhibit 99.1 is described as the OrthoPediatrics Corp. Investor Presentation dated October 2026.
  • Furnished, not filed: According to the filing, the information in Item 7.01 "shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934."
  • Signatory: The report was signed by Daniel J. Gerritzen, General Counsel and Secretary.

OrthoPediatrics Discloses Upcoming Investor Presentations Under Regulation FD

OrthoPediatrics Corp. (NASDAQ:KIDS), a Delaware corporation headquartered at 2850 Frontier Drive, Warsaw, Indiana, submitted a Form 8-K current report dated October 27, 2026, under Item 7.01 (Regulation FD Disclosure). According to the filing, the company's executive officers have "several upcoming presentations to representatives of investors and analysts" and intend to use the material filed as Exhibit 99.1, in whole or in part, as part of those presentations.

The filing identifies Exhibit 99.1 as the OrthoPediatrics Corp. Investor Presentation dated October 2026. The company disclosed that the information furnished under Item 7.01, including material incorporated by reference from Exhibit 99.1, is furnished rather than filed. The filing states it "shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, as amended... or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing."

Daniel J. Gerritzen, General Counsel and Secretary, signed the report on behalf of OrthoPediatrics Corp. on October 27, 2026. The company's common stock, with a par value of $0.00025 per share, is listed on the Nasdaq Global Market under the trading symbol KIDS.

What Was Disclosed

OrthoPediatrics Corp. disclosed via an October 27, 2026 Form 8-K that its executive officers plan to present an investor presentation (Exhibit 99.1, dated October 2026) at upcoming meetings with investors and analysts, furnished under Regulation FD.